Why aging T cells fail: implications for vaccination
- PMID: 16782020
- PMCID: PMC7129126
- DOI: 10.1016/j.immuni.2006.06.003
Why aging T cells fail: implications for vaccination
Abstract
The decline in CD4+ T cell function with aging contributes to reduced vaccine efficacy. In this commentary, we discuss the factors leading to age-related changes in T cell function and propose how they may be overcome to enhance vaccine efficacy for the elderly.
Figures

References
-
- Chen Q., Liang W.N., Liu G.F., Liu M., Xie X.Q., Wu J., He X., Liu Z.J. Case fatality rate of severe acute respiratory syndromes in Beijing. Biomed. Environ. Sci. 2005;18:220–226. - PubMed
-
- Cook J.M., Gualde N., Hessel L., Mounier M., Michel J.P., Denis F., Ratinaud M.H. Alterations in the human immune response to the hepatitis B vaccine among the elderly. Cell. Immunol. 1987;109:89–96. - PubMed
-
- Ernst D.N., Hobbs M.V., Torbett B.E., Glasebrook A.L., Rehse M.A., Bottomly K., Hayakawa K., Hardy R.R., Weigle W.O. Differences in the expression profiles of CD45RB, Pgp-1 and 3G11 membrane antigens and the pattern of lymphokine secretion by splenic CD4+ T cells from young and aged mice. J. Immunol. 1990;145:1295–1302. - PubMed
-
- Garcia G.G., Miller R.A. Differential tyrosine phosphorylation of zeta chain dimers in mouse CD4 T lymphocytes: effect of age. Cell. Immunol. 1997;175:51–57. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials